← All trials
NCT06333951
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 17, 2024
- Primary completion
- Jun 17, 2029
- Completion date
- Jun 16, 2032
- First posted
- Mar 27, 2024
- Last posted
- Nov 4, 2024
- Enrollment
- 500
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.